ImmunoGen Signs 89,000-SF HQ Lease

WALTHAM, MA-In one of the bigger coups for suburban Boston’s life sciences sector, ImmunoGen Inc. is relocating here from East Cambridge, parties involved in the transaction have announced. The firm will occupy 89,000 sf of 830 Winter St., a 182,000-sf Class A building overlooking Route 128 that is owned by Intercontinental Real Estate Corp. of Brighton.

“Intercontinental is pleased to have ImmunoGen as a tenant and we look forward to a long-lasting relationship with such a reputable company,” says Thomas Taranto, head of asset and portfolio management for the landlord. ImmunoGen CFO Daniel Junius cited the ability to combine all of the firm’s administrative and research functions in a single facility as key to their decision to vacate one of the world’s top concentrations for life sciences companies. “We think 830 Winter St. is ideally suited to our needs and will provide us high-quality lab and office space for many years,” says Junius.